This compound is a customized synthesis product. We have a strong synthesis team with excellent synthesis technology and capabilities. However, due to various objective factors, there is a low probability that the synthesis will not be successful. If you need to learn more, please feel free to consult us, we will serve you wholeheartedly.
This compound is a customized synthesis product. We have a strong synthesis team with excellent synthesis technology and capabilities. However, due to various objective factors, there is a low probability that the synthesis will not be successful. If you need to learn more, please feel free to consult us, we will serve you wholeheartedly.
PI-103 Hydrochloride
Catalog No. T6143L CAS
371935-79-4
PI-103 Hydrochloride is a potent dual inhibitor of PI3K and mTOR, demonstrating inhibitory IC50 values of 8 nM for p110α, 88 nM for p110β, 48 nM for p110δ, 150 nM for p110γ, 20 nM for mTORC1, and 83 nM for mTORC2, respectively. Additionally, it inhibits DNA-PK with an IC50 of 2 nM and induces autophagy [1] [2] [3] [4].
All TargetMol products are for research or drug registration purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose in violation of laws and regulations.
PI-103 Hydrochloride is a potent dual inhibitor of PI3K and mTOR, demonstrating inhibitory IC50 values of 8 nM for p110α, 88 nM for p110β, 48 nM for p110δ, 150 nM for p110γ, 20 nM for mTORC1, and 83 nM for mTORC2, respectively. Additionally, it inhibits DNA-PK with an IC50 of 2 nM and induces autophagy [1] [2] [3] [4].
In vitro
PI-103 is demonstrated to possess antiproliferative effects across various human cancer cell lines, acting essentially as a cytostatic agent by inducing cell cycle arrest in the G1 phase [1]. Additionally, it significantly inhibits leukemic proliferation, reduces the clonogenic potential of leukemic progenitors, and triggers mitochondrial apoptosis, particularly targeting the leukemic stem cell compartment [2]. It effectively targets both rapamycin-sensitive (mTORC1, IC 50=20 nM) and rapamycin-insensitive (mTORC2, IC 50=83 nM) complexes of the mTOR protein kinase, showcasing its potent inhibitory action [4].
In vivo
PI-103 demonstrates therapeutic efficacy against various human tumor xenografts, displaying notable inhibition of angiogenesis, invasion, metastasis, along with direct antiproliferative effects [1]. Furthermore, it induces immunosuppression which facilitates in vivo tumor growth while inhibiting apoptosis. Moreover, tumors in mice treated with PI-103 exhibit elevated levels of cyclin D1 and an increased number of proliferating cells [3].
Molecular Weight
384.82
Formula
C19H17ClN4O3
CAS No.
371935-79-4
Storage
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dose Conversion
You can also refer to dose conversion for different animals.
More
Method for preparing DMSO master liquid: mg
drug pre-dissolved in μL DMSO (Master liquid concentration
mg/mL),
Method for preparing in vivo formulation:Take μL
DMSO master liquid, next add μL PEG300, mix and clarify, next add μL
Tween 80,mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation:Take μL
DMSO master liquid, next add μL Corn oil,mix and clarify.
Note:
Be sure to add the solvent(s) in order. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
Calculator
Molarity Calculator
Dilution Calculator
Reconstitution Calculation
Molecular Weight Calculator
bottom
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.